Obesity Clinical Trial
Official title:
Research on Brain Function of Metabolism-based Artificial Intelligence Assisted Clinical Classification of Obesity
The purpose of this study was to investigate the differences and similarities of brain function in patients with four subtypes of obesity, and the relationship between brain function changes and complications after weight loss and metabolic improvement. 120 patients with obesity and 30 healthy individuals with normal BMI were enrolled.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - age ranged from 16-65 years old - BMI over 37.5kg/m2, or BMI over 32.5kg/m2 with diabetes which meets the recommended cut-off bariatric surgery of the Guidelines for surgical treatment of obesity accompanied with or without type 2 diabetes in China. Exclusion Criteria: - secondary causes of obesity such as hypothalamic obesity, Cushing syndrome, hypophysis dysfunction, etc - pregnancy or location - contraindications for laparoscopic surgery, such as gastrointestinal diseases of intra-abdominal infection, adhesion, etc - severe heart, liver, and kidney dysfunction - organic and systemic diseases intolerant of surgery. |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Tenth People's Hospital | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai 10th People's Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional magnetic resonance imaging of brain | The subjects underwent fMRI scans before and after eating. Blood oxygen levels depend on functional brain imaging (Blod-fMRI) to collect the brain's local BLOD response (hemodynamic response) caused by the electrical activity of neurons. The stronger the BLOD response, the more excitability of the local brain.
A region-of-interest (ROI) approach was applied with the use of masks that were established in an independent study of normal-weight subjects to be markers of satiety or predictors of food choices. ROIs included the left and right ventral striatum (nucleus accumbens), the left and right amygdala, the left and right dorsal striatum (caudate and putamen), the left and right insula, and the medial orbital frontal cortex (mOFC). functional connectivity analysis analyzes the compatibity of temporal signals of two or more pairs of brain regions or the differences in the strength of functional connections under different experimental conditions |
6 months | |
Secondary | BMI | BMI=weight(kg)/height(m)^2 | 12 months | |
Secondary | Waist/hip Ratio | WHR(waist-hip ratio)=Waist Circumference in centimeter/Hip Circumference in centimeter | 12 months | |
Secondary | DXA(dual energy x-ray absorptiometry) | Dual X-ray Absorptiometry body composition analysis | 12 months | |
Secondary | Abdominal Fat Measurement | Abdominal Fat Measurement by B-mode Ultrasound | 12 months | |
Secondary | FBG | fasting blood-glucose in mmol/L | 12 months | |
Secondary | PBG | postprandial blood-glucose in mmol/L | 12 months | |
Secondary | FINS | fasting serum insulin in mU/L | 12 months | |
Secondary | PINS | postprandial insulin in mU/L | 12 months | |
Secondary | ALT | alanine aminotransferase in U/L | 12 months | |
Secondary | AST | aspartate aminotransferase in U/L | 12 months | |
Secondary | UA | Uric acid in umol/L | 12 months | |
Secondary | HOMA-IR | Homeostatic model assessment insulin resistance index=FBG*FINS/22.5 | 12 months | |
Secondary | HbA1c (%) | Glycated hemoglobin | 12 months | |
Secondary | LDL-C | low-density lipoprotein cholesterol in mmol/L | 12 months | |
Secondary | HDL-C | Hight-density lipoprotein cholesterol in mmol/L | 12 months | |
Secondary | TT | total testosterone in nmol/L | 12 months | |
Secondary | SHBG | sex hormone-binding globulin in nmol/L | 12 months | |
Secondary | TSH | thyroid stimulating hormone in µIU/ml | 12 months | |
Secondary | FT3 | free triiodothyronine in pmol/L | 12 months | |
Secondary | FT4 | free thyroxine in pmol/L | 12 months | |
Secondary | FT | free testosterone (nmol/L) | 12 months | |
Secondary | DHEAS | Dehydroepiandrosterone Sulfate (ug/dl) | 12 months | |
Secondary | PTH | parathyroid hormone in (ng / L) | 12 months | |
Secondary | 25OHD | 25 hydroxyvitamin D in (nmol / L) | 12 months | |
Secondary | Ca | serum calcium in (mmol/L) | 12 months | |
Secondary | GLP-1 | Glucagon-like peptide-1(pmol/L) | 12 months | |
Secondary | LCN2 | Lipocalin 2 level | 12 months | |
Secondary | Ghrelin | Ghrelin level | 12 months | |
Secondary | Leptin | Leptin level | 12 months | |
Secondary | S100 | S100 protein level | 12 months | |
Secondary | GFAP | Glial fibrillary acidic protein level | 12 months | |
Secondary | TEFQ-R21 | The TFEQ-R21 consisted of 21 items rated on a four-point Likert scale. We averaged the scores (ranging from 1 to 4) for the overall items as well as the items within the subdomain of each item, i.e., EE, UE, and CR, where a higher score indicated a more dysfunctional eating behavior. | 12 months | |
Secondary | HADS | HADS consists of two subscales: HADS-A, designed to detect anxious states, and HADS-D, designed to detect depressive states. Each subscale consists of seven items with a 4-point ordinal response format. Scores ranges from 0 to 21 in each subscale, with higher scores indicating higher levels of anxious or depressive state. Participants answer each item thinking of how they felt and/or behaved during the past week. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |